FDA Inspection 1205427 — CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services
The FDA completed an inspection of CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services on May 3, 2023 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 3, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)